Pharming Group has sawed off its gene therapy collaboration with Orchard Therapeutics, a decision that will see the end of a preclinical hereditary angioedema (HAE) program.. Netherlands-based ...

Pharming Group (NASDAQ: NASDAQ:PHAR) stands as a globally recognized biotechnology firm based in the Netherlands.It is best known for its unique approach to addressing rare and genetic diseases ...

Leiden, the Netherlands, June 24, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces it will host a webcast for investors and analysts featuring ...

Pharming Group reports third quarter 2023 financial results. Third quarter 2023 revenues increased 23% to US $66.7 million, ... genetic testing family members of APDS patients, ...

The disease was first characterized in 2013 and can now be diagnosed with genetic testing. According to Pharming, APDS affects an estimated 1 million to 2 million people worldwide.

The U.S. Food and Drug Administration (FDA) on Friday approved Pharming Group's drug to treat a rare genetic disorder that leads to a weakened immune system, the Dutch company said.

Pharming Group (PHGUF) reported a 42% increase in total revenues for Q1 2025, driven by strong sales of Ruconest and Joenja. Ruconest sales grew by 49% to $68.6 million, supported by increased ...

Pharming Group N.V., a biopharmaceutical company, ... It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE.

Pharming is paying $66.1 million to acquire Swedish biotech Abliva and its phase 2-stage med that the Dutch drugmaker believes has blockbuster potential with a type of mitochondrial disease.. At ...

New methods help lift genetic uncertainty. ... This work was also supported in part through a sponsored research agreement with Pharming; the NIH (grants R37CA258829, R01CA266446, R01CA280414 ...

Fabrice Chouraqui, Chief Executive Officer of Pharming, said: ... including permanent lung damage and lymphoma. 4-7 A definitive diagnosis can be made through genetic testing.